Willingness to Use Long-Acting Injectable Cabotegravir for HIV Prevention Among Female Students
Author Information
Author(s): Atuhaire Bridget, Muteebwa Laban, Nabunya Racheal, Muhindo Richard, Ngabirano Tom Denis, Osingada Charles Peter, Muwanguzi Patience
Primary Institution: Makerere University
Hypothesis
What factors influence the willingness of female undergraduate students at a Ugandan university to use long-acting Cabotegravir for HIV prevention?
Conclusion
Educational initiatives on innovative HIV prevention strategies, such as CAB-LA, should be introduced early in university students’ studies to increase awareness and acceptance.
Supporting Evidence
- 56.7% of female university students were willing to use CAB-LA.
- Willingness was significantly associated with being sexually active in the past 3 months.
- Fourth-year students were more willing to use CAB-LA compared to first-year students.
Takeaway
This study found that more than half of female university students in Uganda are willing to use a new HIV prevention method called CAB-LA, which is given as an injection every two months.
Methodology
A cross-sectional study using an online questionnaire to survey female undergraduate students aged 18–25.
Limitations
The study's focus on health profession students at one public university limits its generalizability.
Participant Demographics
Female undergraduate students aged 18–25 from a Ugandan public university.
Statistical Information
P-Value
0.05
Confidence Interval
95% CI: 51.4 to 61.8
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website